FDA asks Allergan to recall textured breast implants worldwideBreast implants, CancerAllergan Plc is recalling the company’s Biocell textured breast implants and tissue expanders across markets, citing concerns over a rare form of cancer, after the U.S. health agency asked the drugmaker to pull the products. Read more July 24, 2019/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2019-07-24 08:55:432019-07-24 12:51:20FDA asks Allergan to recall textured breast implants worldwide